DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), an innovator in point-of-care ocular diagnostics, is pleased to announce positive interim analytical results from ...
Peer-reviewed journal Clinical Chemistry published the first head-to-head study comparing GraftAssureâ„¢ to industry-leading ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results